MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation Market Cap 2011-2026 | IART
As of February 13, 2026 Integra LifeSciences Holdings Corporation has a market cap of $ 832 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.88 B | 3.08 B | 4.67 B | 5.48 B | 5.59 B | 4.73 B | 3.92 B | 4.14 B | 3.07 B | 2.27 B | 1.82 B | 1.32 B | 1.18 B | 796 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.59 B | 796 M | 3.14 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M |  USA |
 |
AxoGen
AXGN
|
859 M | $ 32.61 | -3.81 % | $ 1.44 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
45.7 M | $ 3.82 | -2.55 % | $ 132 M | USA |
 |
Alphatec Holdings
ATEC
|
1.55 B | $ 13.1 | -2.75 % | $ 1.87 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
661 M | $ 6.87 | -4.58 % | $ 493 M |  Israel |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Bio-Rad Laboratories
BIO
|
7.81 B | $ 292.42 | - | $ 8.25 B | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 37.51 | -11.6 % | $ 5.59 K | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
1.94 B | $ 41.67 | - | $ 1.29 B | USA |
 |
Boston Scientific Corporation
BSX
|
155 B | $ 74.12 | - | $ 109 B | USA |
 |
Abbott Laboratories
ABT
|
235 B | $ 111.47 | -1.87 % | $ 194 B | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
466 M | $ 13.04 | -2.47 % | $ 352 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
60 M | $ 4.77 | -2.65 % | $ 178 M |  France |
 |
Electromed
ELMD
|
175 M | $ 23.31 | - | $ 197 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | USA |
 |
InMode Ltd.
INMD
|
1.43 B | $ 14.3 | 0.42 % | $ 1.13 B | Israel |
 |
IRadimed Corporation
IRMD
|
670 M | $ 99.84 | -3.14 % | $ 1.26 B | USA |
 |
Integer Holdings Corporation
ITGR
|
4.58 B | $ 85.36 | - | $ 2.87 B | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.54 | -0.22 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
11.4 B | $ 87.22 | - | $ 11.8 B | USA |
 |
Pulmonx Corporation
LUNG
|
341 M | $ 1.42 | -2.07 % | $ 55.5 M | USA |
 |
Myomo
MYO
|
5.64 M | $ 0.81 | 1.35 % | $ 5.71 M | USA |
 |
Establishment Labs Holdings
ESTA
|
1.2 B | $ 73.54 | 1.13 % | $ 2.07 B |  Costa-rica |
 |
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.38 | -3.5 % | $ 22.3 M | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.64 | 2.39 % | $ 34.8 M | USA |